SCHEDULE 13D//SEC Filing
BridgeBio Oncology Therapeutics, Inc. SCHEDULE 13D
Accession 0001193125-25-182790
CIK 0002076615other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 5:41 PM ET
Size
61.1 KB
Accession
0001193125-25-182790
Issuer
BridgeBio Pharma LLC
CIK 0002076615
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0002076615
Filing Metadata
- Form type
- SCHEDULE 13D
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 5:41 PM ET
- Size
- 61.1 KB